NTRK1 and colorectal carcinoma: Further cases of CRC harbouring either NTRK1 or NTRK3 gene fusions involving different partner genes have subsequently been reported and, in some cases, demonstrated pharmacologically actionable (Figure 4) [44, 45, 71–73].